Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial

David Neal Franz, Elena Belousova, Steven Sparagana, E. Martina Bebin, Michael Frost, Rachel Kuperman, Olaf Witt, Michael H. Kohrman, J. Robert Flamini, Joyce Y. Wu, Paolo Curatolo, Petrus J. De Vries, Vicky H. Whittemore, Elizabeth A. Thiele, James P. Ford, Gaurav Shah, Helene Cauwel, David Lebwohl, Tarek Sahmoud, Sergiusz Jozwiak

Neurology & Neurotherapeutics - NE Outside Agreements
Neurology & Neurotherapeutics

Research output: Contribution to journal › Article › peer-review

645 Scopus citations

Sort by
Weight
Alphabetically

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial

Fingerprint

Medicine & Life Sciences